FDA Approved: EZETIMIBE AND SIMVASTATIN — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved Ascend Laboratories' supplemental application for the generic fixed-dose combination ezetimibe and simvastatin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Hyperlipidemia

Drugs mentioned

• EZETIMIBE AND SIMVASTATIN (ezetimibe and simvastatin)

Snippet

SUPPL AP for EZETIMIBE AND SIMVASTATIN (EZETIMIBE AND SIMVASTATIN)